EUVIMEDEUVIMED entdecken
Crossref

Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy

Jongyoon Shinn, Seojeong Park, Seonju Lee, Nayoon Park, Seojeong Kim, Seohui Hwang, James J Moon, Youngjoo Kwon iD, Yonghyun Lee iD

ACS Nano · 13.02.2024 · 18 (6) · 4704-4716

DOI: 10.1021/acsnano.3c06107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 30.01.2024. Verfasst von Jongyoon Shinn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy, Ewha Womans University, Seoul 03760, South Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, Ministry of Education, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseMiceAnimalsAntioxidantsHyaluronic AcidBilirubinHepatic Stellate CellsNanomedicineLiver CirrhosisLiverFibrosisCollagenMice, Inbred C57BL

Stichwörter der Autor:innen

Activated hepatic stellate cellsAnti-liver-fibrosis therapyAntioxidative therapyBilirubinHyaluronic acidNASHNanomedicineNonalcoholic steatohepatitis

Substanzen

AntioxidantsHyaluronic AcidBilirubinCollagen

Autor:innen und Institutionen

  • Department of Pharmacy, College of Pharmacy, Ewha Womans University, Seoul 03760, South Korea.
  • Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.

ORCID-Profile: Youngjoo Kwon, Yonghyun Lee

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Education
  • National Research Foundation of Korea

Zitieren

APA

Shinn, J., Park, S., Lee, S., Park, N., Kim, S., Hwang, S., Moon, J. J., Kwon, Y., & Lee, Y. (2024). Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy. ACS Nano, 18(6), 4704-4716. https://doi.org/10.1021/acsnano.3c06107

Vancouver

Shinn J, Park S, Lee S, Park N, Kim S, Hwang S, et al. Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy. ACS Nano. 2024;18(6):4704-4716. doi:10.1021/acsnano.3c06107

BibTeX
@article{Shinn2024,
  author = {Shinn, Jongyoon and Park, Seojeong and Lee, Seonju and Park, Nayoon and Kim, Seojeong and Hwang, Seohui and Moon, James J and Kwon, Youngjoo and Lee, Yonghyun},
  title = {Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {6},
  pages = {4704--4716},
  doi = {10.1021/acsnano.3c06107}
}
Kostenlos starten →